Myopia Management
A closer look at pediatric myopia
A growing concern that CooperVision® can help you address
The prevalence of myopia in North America has increased 50%, from 28% to 42% over the last two decades.1 Among Canadian school children aged 11-13, almost 30% are myopic.2 Two-thirds of Eye Care Practitioners (ECPs) say the presence of myopia among children in their practice has increased over the past 5-10 years†, and 81% of ECPs agree that myopia is one of the biggest problems impacting children’s eyesight today.§
What's causing the rising prevalence of myopia?
The upward incidence of myopia in today’s children can be attributed to different factors, and is occasionally the result of a combination of these factors:
Genetics
Family eyesight history plays a role in a child’s risk of myopia. The likelihood of children developing myopia is:
1 in 2
when both parents are myopic3
1 in 3
when one parent is myopic3
1 in 4
when neither parent is myopic3
Environment
Research shows that a child’s environment and habits may influence the development of myopia.
In short, more myopic parents means more myopic children – and the more that children stay inside and utilize digital devices, the more likely we are to see new myopes.
Nearsightedness Assessment Tool
Find out what to do if your child is nearsighted.
Take our short quiz to understand more about nearsightedness and your child.
Take the quizAn absence of urgency to address myopia can lead to future risks
Today, only 56% of ECPs agree that myopia, left untreated, increases the risk of irreversible vision loss.2 But myopic progression has been linked to more severe sight-threatening complications later in life, including6-9:
- Retinal Detachment
- Myopic Maculopathy
- Glaucoma
- Cataracts
A modern approach for today's myopia
With the FDA approval⌂ of MiSight® 1 day, the cornerstone of the Brilliant FuturesTM Myopia Management Program, CooperVision continues to be a leader in meaningful industry innovation. Canadian Eye Care Practitioners can now join their colleagues from across the globe in changing the futures of young patients with myopia.
If you’re interested in becoming certified and offering the Brilliant FuturesTM Myopia Management Program to your patients, click below to fill out the form and register for more information.
⌂USA Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
† CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey 6/27/19 – 7/18/19 of n=313 ECPs (who see at least 1/month myopic child, age 8-15) in U.S. Slightly or significantly increased.
‡ Data on file. CooperVision, Inc. Victor, NY. The Harris Poll online survey of n=1,005 patients (with child age 8-15) and ECPS (who see at least 1 child age 8-15 with myopia each month) in U.S.
§ CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey 6/27/19 – 7/18/19 of n=313 ECPs (who see at least 1/month myopic child, age 8-15) in U.S. ODs (89%) and MDs (68%) strongly/somewhat agree.]
1. Holden BA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-42.
2. Yang, M., Luensmann, D., Fonn, D. et al. Myopia prevalence in Canadian school children: a pilot study. Eye 32, 1042–1047 (2018). https://doi.org/10.1038/s41433-018-0015-5
3. Morgan P. C52102: Is myopia control the next contact lens revolution? 2016. Available from https://www.opticianonline.net/cet-archive/127.
4. Rose KA, Morgan IG, Ip J, et al. Outdoor Activity Reduces the Prevalence of Myopia in Children. Ophthalmology 2008;115(8):1279-1285
5. Wolffsohn JS, Calossi A, Cho P, et al. Global Trends in Myopia Management Attitudes and Strategies in ClinicalPractice. Cont Lens Anterior Eye. 2016;39(2):106-16.
6. Xu L, Wang Y, Wang S, Jonas JB. High myopia and glaucoma susceptibility, the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20.
7. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2013;31(6):622-60.
8. Younan C, et al. Myopia and incident cataract and cataract surgery: the blue mountains eye study. Invest Ophthalmol Vis Sci. 2002;43(12):3625-3632.
9. Chen SJ, et al. Prevalence and associated risk factors of myopic maculopathy in elderly Chinese: the Shihpai eye study. Invest Ophthalmol Vis Sci. 2012;53(8):4868-73.
Brilliant FuturesTM Myopia Management Program
More than just a contact lens, a chance to change the future
A new standard of care for your myopic patients
The Brilliant FuturesTM Myopia Management Program is a comprehensive approach to myopia management specifically designed for your pediatric patients and their busy parents. Built around MiSight® 1 day contact lenses – the first and only FDA approved* soft contact lenses to help slow the progression of myopia in children age 8-12 at initiation of treatment1** – this program allows you to do more for your pediatric myopia patients.
The Brilliant FuturesTM Myopia Management Program supports your practice and patients every step of the way.
If you’re interested in becoming certified and offering the Brilliant FuturesTM Myopia Management Program to your patients, click below to fill out the form and register for more information.
*USA Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
**Compared to a single vision 1 day lens over a 3 year period.
1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556–67.
.
MiSight® 1 day
MiSight® 1 day contact lenses are the first and only FDA-approved* soft contact lenses to slow the progression of myopia in children age 8-12 at initiation of treatment.1**
See myopia management through a new lens
Clinically proven outcomes
MiSight® 1 day contact lenses were clinically validated in a multi-year comprehensive study that enrolled children age 8-12 years old.1
How MiSight® 1 day contact lenses work
The ActivControlTM Technology in MiSight® 1 day uses vision correction zones and treatment zones within the lenses to slow the axial elongation of the eyeball.1-3
By including both types of zones in the lens, it simultaneously corrects the child’s vision, while creating myopic defocus in all gazes.1
MiSight® 1 day contact lenses are patient and parent approved
Incorporating this technology into a 1-day disposable lens was based on the safety profile of lenses that are discarded after one day of use, as well as children’s ease of use and parental peace of mind. For children and parents, a multi-center study found1:
The additional benefits of contact lenses for children
Beyond standard vision correction, myopia management with a soft contact lens provides children with additional lifestyle benefits.
- Offering a comfortable wearing experience6
- Avoiding the worry of losing or breaking glasses
- Accomodating a more active lifestyle7
- Providing children who wear contact lenses a significantly better quality of life than kids wearing glasses, especially regarding athletics and appearance8
*USA Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
**Compared to a single vision 1 day lens over a 3 year period.
†How much do you like wearing your contact lenses?' 87/97 (90%) Top box 'I like contact lenses the best' Subjective response @60M]
‡ As reported by parents
§ Overall experience as defined as children's comfort, vision, lens handling, and freedom from spectacles. Children aged 8-15 years.
1. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556–67.
2. La liste des nominés aux 26e SILMO d’Or. (2019, September 25). Retrieved October 2, 2019, from https:// en.silmoparis.com/Silmo-d-Or-Awards/Nominees-2019.
3. Optician. (2018, April 4). Optician Awards 2018: Black ties and glittering prizes. Retrieved October 2, 2019, from https://www.opticianonline.net/news/optician-awards-2018- black-ties-and-glittering prizes.
4. CooperVision data on file 2018. 3-year study report.
5. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster
6. Walline JJ, et al. Benefits of contact lens wear for children and teens. Eye Contact Lens. 2007;33(6 Pt 1):317-21.
7. Rah MJ, et al. Vision specific quality of life of pediatric contact lens wearers. Optom Vis Sci. 2010;87(8):560-6.
The Certification Process
To bring the Brilliant FuturesTM Myopia Management Program into your practice, the first step is to complete the certification training.
Become a Brilliant FuturesTM Certified Practice
Certification is required for all Eye Care Practitioners who want to offer the Brilliant FuturesTM Myopia Management Program. Upon completion of the training, you’ll be invited to take a short online exam, the successful completion of which officially signifies your certification as a Brilliant FuturesTM Myopia Management Program prescriber. Upon successful completion of the exam, you’ll receive the following:
A certificate of training completion
An introduction to your dedicated Myopia Management Specialist
Practitioner starter kit available upon request
One Practitioner starter kit
Parent and child starter kits upon request
Marketing tools to support your practiceTo help ensure your success with this new program, CooperVision will continue to provide educational and marketing support beyond initial certification.
If you’re interested in becoming certified and offering the Brilliant FuturesTM Myopia Management Program to your patients, click below to fill out the form and register for more information.
Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
